Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009 by Goethe University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
University Hospital Heidelberg
Information provided by:
Goethe University
ClinicalTrials.gov Identifier:
NCT01168167
First received: July 21, 2010
Last updated: July 22, 2010
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2011
  Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)